Metoprolol is available in several forms with the following active ingredients: Immediate-release oral (taken by mouth) ...

Brand-name versions of metoprolol ... Tartrate for Adults High Blood Pressure 50 milligrams (mg) twice daily 100–400 mg per ...

Metoprolol succinate 25mg, 50mg, 100mg, 200mg; scored ext-rel tabs. Toprol-XL Tablets are supplied in 100- and 1000-count bottles in the following strengths: 25 mg: white, biconvex, film-coated ...

[16] Twenty-seven patients were randomized to receive either immediate- release metoprolol tartrate 50 mg twice a day (n = 14) or extended- release metoprolol succinate 95 mg (equivalent to ...

Researchers and pharmaceutical companies have for years banked on the potential of pot to help tackle everything from anxiety to cancer. But there have been no FDA-approved medications derived ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

Metoprolol succinate 25mg, 50mg, 100mg, 200mg; ext-rel caps. Metoprolol is a beta 1-selective (cardioselective) adrenergic receptor blocking agent. This preferential effect is not absolute ...

Following informed consent, patients were randomized (in strata according to time of onset, diabetes status, sex, and age) to the treatment arm (up to three 5-mg boluses of metoprolol tartrate at ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

There is evidence to indicate that full adrenergic blockade by carvedilol improves survival and cardiovascular outcome in patients with heart failure compared with metoprolol treatment ...

When it comes to claiming market control, pharmaceutical companies stand apart from healthcare’s other monopolies. Whereas hospitals and health systems rely primarily on mergers and acquisitions ...

From a technical perspective, Vertex Pharmaceuticals (VRTX) is looking like an interesting pick, as it just reached a key level of support. VRTX recently overtook the 50-day moving average ...